Sign Up
OverviewAPI
The article underscores the link between price controls and drug shortages, focusing on essential hospital medications like Methotrexate and fludarabine. It delves into the FTC's investigation of distribution companies such as Cardinal Health and hospital purchasing firms like HealthTrust. Emphasizing the critical role of competition in the generic drug sector, it highlights regulatory obstacles and labor shortages impacting drug production, advocating for a harmonious balance between profit and healthcare quality.

Ask a question